Literature DB >> 28285734

Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.

Jibran Y Khokhar1, Travis P Todd2.   

Abstract

Alcohol use disorder commonly occurs in patients with schizophrenia and contributes greatly to its morbidity. Unfortunately, the neural and behavioral underpinnings of alcohol drinking in these patients are not well understood. In order to begin to understand the cognitive and reward-related changes that may contribute to alcohol drinking, this study was designed to address: 1) latent inhibition; 2) conditioning; and 3) extinction of autoshaping in a neurodevelopmental rat model with relevance to co-occurring schizophrenia and alcohol use disorders, the neonatal ventral hippocampal lesioned (NVHL) rat. NVHL lesions (or sham surgeries) were performed on post-natal day 7 (PND7) and animals were given brief exposure to alcohol during adolescent (PND 28-42). Latent inhibition of autoshaping, conditioning and extinction were assessed between PND 72-90. On PND90 animals were given alcohol again and allowed to establish stable drinking. Latent inhibition of autoshaping was found to be prolonged in the NVHL rats; the NVHL rats pre-exposed to the lever stimulus were slower to acquire autoshaping than sham pre-exposed rats. NVHL rats that were not pre-exposed to the lever stimulus did not differ during conditioning, but were slower to extinguish conditioned responding compared to sham controls. Finally, the NVHL rats from both groups drank significantly more alcohol than sham rats, and the extent of latent inhibition predicted future alcohol intake in the pre-exposed animals. These findings suggest that the latent inhibition of autoshaping procedure can be used to model cognitive- and reward-related dysfunctions in schizophrenia, and these dysfunctions may contribute to the development of co-occurring alcohol use.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoshaping; Dual diagnosis; Ethanol; Latent inhibition; NVHL; Sign-tracking

Mesh:

Year:  2017        PMID: 28285734      PMCID: PMC5591749          DOI: 10.1016/j.schres.2017.02.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  44 in total

Review 1.  The pharmacology of latent inhibition as an animal model of schizophrenia.

Authors:  P C Moser; J M Hitchcock; S Lister; P M Moran
Journal:  Brain Res Brain Res Rev       Date:  2000-09

2.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

3.  Executive functioning in individuals with schizophrenia and/or cocaine dependence.

Authors:  Irina Benaiges; Josep Maria Serra-Grabulosa; Gemma Prat; Ana Adan
Journal:  Hum Psychopharmacol       Date:  2012-11-20       Impact factor: 1.672

4.  Clinical features of latent inhibition in schizophrenia.

Authors:  C Rascle; O Mazas; G Vaiva; M Tournant; O Raybois; M Goudemand; P Thomas
Journal:  Schizophr Res       Date:  2001-09-01       Impact factor: 4.939

Review 5.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

6.  Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: a brain stimulation reward study.

Authors:  Alexandra Gallo; Claude Bouchard; Emmanuel Fortier; Charles Ducrot; Pierre-Paul Rompré
Journal:  Eur Neuropsychopharmacol       Date:  2014-07-19       Impact factor: 4.600

7.  Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.

Authors:  Viviane Labrie; Tatiana Lipina; John C Roder
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

Review 8.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

Review 9.  Neural substrates of latent inhibition: the switching model.

Authors:  I Weiner
Journal:  Psychol Bull       Date:  1990-11       Impact factor: 17.737

10.  Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia.

Authors:  Anne Marie Brady; Sarah E McCallum; Stanley D Glick; Patricio O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2008-05-26       Impact factor: 4.530

View more
  4 in total

1.  Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents.

Authors:  Bryan W Jenkins; Shoshana Buckhalter; Melissa L Perreault; Jibran Y Khokhar
Journal:  Schizophr Bull Open       Date:  2021-11-20

2.  The Impact of Adolescent Alcohol Exposure on Nicotine Behavioral Sensitization in the Adult Male Neonatal Ventral Hippocampal Lesion Rat.

Authors:  Emily D K Sullivan; Liam N Locke; Diana J Wallin; Jibran Y Khokhar; Elise M Bragg; Angela M Henricks; Wilder T Doucette
Journal:  Front Behav Neurosci       Date:  2021-11-11       Impact factor: 3.558

3.  Maternal immune activation and adolescent alcohol exposure increase alcohol drinking and disrupt cortical-striatal-hippocampal oscillations in adult offspring.

Authors:  Emily D K Sullivan; Lucas L Dwiel; Angela M Henricks; Judy Y Li; Diana J Wallin; Jibran Y Khokhar; Wilder T Doucette
Journal:  Transl Psychiatry       Date:  2022-07-20       Impact factor: 7.989

4.  Glutamine and GABA alterations in cingulate cortex may underlie alcohol drinking in a rat model of co-occurring alcohol use disorder and schizophrenia: an 1H-MRS study.

Authors:  Patrick McCunn; Xi Chen; Barjor Gimi; Alan I Green; Jibran Y Khokhar
Journal:  Schizophrenia (Heidelb)       Date:  2022-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.